当前位置: 首页 >> 检索结果
共有 7728 条符合本次的查询结果, 用时 4.2090774 秒

5921. Normalized Subendocardial Myocardial Attenuation on Coronary Computed Tomography Angiography Predicts Postoperative Adverse Cardiovascular Events: Coronary CTA VISION Substudy.

作者: Jeroen Walpot.;Samia Massalha.;Pranisha Jayasinghe.;Madiha Sadaf.;Owen Clarkin.;Laura Godkin.;Ashwin Sharma.;Indeevari Ratnayake.;Kara Godkin.;Kateleen Jia.;Alomgir Hossain.;Andrew M Crean.;Matthew Chan.;Craig Butler.;Vikas Tandon.;Peter Nagele.;Pamela K Woodard.;Marko Mrkobrada.;Wojciech Szczeklik.;Yang Faridah Abdul Aziz.;Bruce Biccard.;P J Devereaux.;Tej Sheth.;Benjamin J W Chow.
来源: Circ Cardiovasc Imaging. 2022年15卷1期e012654页
Abnormalities in computed tomography myocardial perfusion has been associated with coronary artery disease and major adverse cardiovascular events (MACE). We sought to investigate if subendocardial attenuation using coronary computed tomography angiography predicts MACE 30 days postelective noncardiac surgery.

5922. Circulation: Cardiovascular Imaging's Top Ten Reviewers of 2020 to 2021.

作者: Robert J Gropler.; .
来源: Circ Cardiovasc Imaging. 2022年15卷1期e013894页

5923. Trajectory of Left Ventricular Remodeling in Children With Valvar Aortic Stenosis Following Balloon Aortic Valvuloplasty.

作者: Koyelle Papneja.;Zachary M Blatman.;Ian D Kawpeng.;Jacqueline Wheatley.;Hanne Oscé.;Boning Li.;Myriam Lafreniere-Roula.;Chun P S Fan.;Cedric Manlhiot.;Lee N Benson.;Luc Mertens.
来源: Circ Cardiovasc Imaging. 2022年15卷1期e013200页
Aortic valve stenosis is the most common type of congenital left ventricular (LV) outflow tract obstruction. Balloon aortic valvuloplasty (BAV) has become the first-line treatment pathway in many centers. Our aim was to assess the trajectory of LV remodeling following BAV in children and its relationship to residual aortic stenosis (AS) and insufficiency (AI).

5924. Patterns of Early Coronary Artery Changes in Pediatric Heart Transplant Recipients Detected Using Optical Coherence Tomography.

作者: Sabine L Laguë.;Jeffrey N Bone.;Rosh Samuel.;Christine Voss.;Enrique Balbacid.;Martin C K Hosking.;Stephan Schubert.;Kevin C Harris.
来源: Circ Cardiovasc Imaging. 2022年15卷1期e012486页
Cardiac allograft vasculopathy, the leading cause of graft failure in pediatric heart transplant recipients, is characterized by diffuse and concentric coronary intimal thickening. Early treatment yields better outcomes. While coronary angiography is the standard for cardiac allograft vasculopathy screening and diagnosis, it only identifies luminal narrowing, which occurs in more severe disease. Coronary optical coherence tomography (OCT) is a high-definition intravascular imaging modality that may offer earlier diagnosis. We used OCT to investigate coronary intimal thickening in pediatric transplant recipients and examined its (1) location (ie, vessel type and location) and (2) nature (ie, characteristics of cross-sectional and longitudinal thickening).

5925. Insights Into Myocardial Oxygenation and Cardiovascular Magnetic Resonance Tissue Biomarkers in Heart Failure With Preserved Ejection Fraction.

作者: Kady Fischer.;Dominik P Guensch.;Bernd Jung.;Iman King.;Hendrik von Tengg-Kobligk.;Nadia Giannetti.;Balthasar Eberle.;Matthias G Friedrich.
来源: Circ Heart Fail. 2022年15卷4期e008903页
The pathophysiology of heart failure with preserved ejection fraction is not well understood, but evidence strongly suggests involvement of microvascular dysfunction. We studied the myocardial oxygenation reserve as a direct marker of coronary vascular function and its relation to myocardial deformation and tissue characteristics by cardiovascular magnetic resonance (CMR).

5926. Unexplained Dyspnea on Exertion: The Difference the Right Test Can Make.

作者: Vishal N Rao.;Michelle D Kelsey.;Michael A Blazing.;Neha J Pagidipati.;Terry A Fortin.;Marat Fudim.
来源: Circ Heart Fail. 2022年15卷2期e008982页

5927. Myocardial Rev-erb-Mediated Diurnal Metabolic Rhythm and Obesity Paradox.

作者: Shiyang Song.;Chih-Liang Tien.;Hao Cui.;Paul Basil.;Ningxia Zhu.;Yingyun Gong.;Wenbo Li.;Hui Li.;Qiying Fan.;Jong Min Choi.;Weijia Luo.;Yanfeng Xue.;Rui Cao.;Wenjun Zhou.;Andrea R Ortiz.;Brittany Stork.;Vatsala Mundra.;Nagireddy Putluri.;Brian York.;Maoping Chu.;Jiang Chang.;Sung Yun Jung.;Liang Xie.;Jiangping Song.;Lilei Zhang.;Zheng Sun.
来源: Circulation. 2022年145卷6期448-464页
The nuclear receptor Rev-erbα/β, a key component of the circadian clock, emerges as a drug target for heart diseases, but the function of cardiac Rev-erb has not been studied in vivo. Circadian disruption is implicated in heart diseases, but it is unknown whether cardiac molecular clock dysfunction is associated with the progression of any naturally occurring human heart diseases. Obesity paradox refers to the seemingly protective role of obesity for heart failure, but the mechanism is unclear.

5928. Response by Brahmbhatt et al to Letter Regarding Article, "Liberation From Venoarterial Extracorporeal Membrane Oxygenation: A Review".

作者: Darshan H Brahmbhatt.;Andrea L Daly.;Adriana C Luk.;Eddy Fan.;Filio Billia.
来源: Circ Heart Fail. 2022年15卷4期e009260页

5929. Ratio of Mixed Venous Oxygen Saturation-to-Pulmonary Capillary Wedge Pressure: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

作者: Dustin Hillerson.;Richard Charnigo.;Sun Moon Kim.;Amrita Iyengar.;Matthew Lane.;Naoki Misumida.;Andrew R Kolodziej.;Gbolahan O Ogunbayo.;Ahmed Abdel-Latif.;John C Gurley.;David C Booth.
来源: Circ Heart Fail. 2022年15卷2期e008838页
Hemodynamic values from right heart catheterization aid diagnosis and clinical decision-making but may not predict outcomes. Mixed venous oxygen saturation percentage and pulmonary capillary wedge pressure relate to cardiac output and congestion, respectively. We theorized that a novel, simple ratio of these measurements could estimate cardiovascular prognosis.

5930. "My Amazing Heart": A Patient's Simple Request to Change Outdated Heart Failure Labels.

作者: Peter K Boulos.;Gary Burgin.;Rachel Johnson-Koenke.;Kelsey M Flint.
来源: Circ Heart Fail. 2022年15卷3期e008679页

5931. Letter by Araj and Hackmann Regarding Article, "Liberation From Venoarterial Extracorporeal Membrane Oxygenation: A Review".

作者: Faris G Araj.;Amy E Hackmann.
来源: Circ Heart Fail. 2022年15卷4期e009079页

5932. Economic Considerations in Access to Transcatheter Aortic Valve Replacement.

作者: Kriyana P Reddy.;Peter W Groeneveld.;Jay Giri.;Alexander C Fanaroff.;Ashwin S Nathan.
来源: Circ Cardiovasc Interv. 2022年15卷2期e011489页
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, with the number of procedures and sites offering the procedure steadily rising over the past decade in the United States. Despite this, growth into certain markets has been limited as hospitals have to balance high TAVR costs with the ability to offer a complete array of state-of-the-art therapies for aortic stenosis. This trade-off often results in decreased access to TAVR services by patients cared for in hospitals that cannot afford these services or have difficulty meeting procedural requirements, recruiting skilled physicians, and initiating and then maintaining a functioning TAVR program. The lack of access is more common among patients of color or those who are socioeconomically disadvantaged. The purpose of this review is to describe the hospital-level economic considerations of TAVR in the United States and the resulting effects on geographic, racial, ethnic, and socioeconomic access for Americans.

5933. Letter by Inker et al Regarding Article, "Pitfalls in Using Estimated Glomerular Filtration Rate Slope as a Surrogate for the Effect of Drugs on the Risk of Serious Adverse Renal Outcomes in Clinical Trials of Patients With Heart Failure".

作者: Lesley A Inker.;Hiddo J L Heerspink.;Edward F Vonesh.;Tom Greene.
来源: Circ Heart Fail. 2022年15卷3期e008983页

5934. SARS-CoV-2-Associated Myocarditis: A Case of Direct Myocardial Injury.

作者: Amanda K Verma.;Olakanmi Olagoke.;Jonathan D Moreno.;Neda Rezaee.;Pan Ma.;Jing Liu.;Ali Javaheri.;Kory Lavine.;Muhammad F Masood.;Chieh-Yu Lin.
来源: Circ Heart Fail. 2022年15卷3期e008273页

5935. The Evolution of Evidence-Based Medicine: When the Magic of the Randomized Clinical Trial Meets Real-World Data.

作者: Seng Chan You.;Harlan M Krumholz.
来源: Circulation. 2022年145卷2期107-109页

5936. Celebrating The Next Generation of Cardiovascular Investigators.

作者: James A de Lemos.;Darren K McGuire.;Joseph A Hill.
来源: Circulation. 2022年145卷2期91-93页

5937. Bidirectional Changes in Myocardial 18F-Fluorodeoxyglucose Uptake After Human Ventricular Unloading.

作者: Tiberiu A Pana.;Jainy Savla.;Ingrid Kepinski.;Adam Fairbourn.;Aneela Afzal.;Pradeep Mammen.;Mark Drazner.;Rathan M Subramaniam.;Chao Xing.;Kathryn A Morton.;Stavros G Drakos.;Vlad G Zaha.;Hesham A Sadek.
来源: Circulation. 2022年145卷2期151-154页

5938. Validation of Blood Pressure Device Accuracy: When the Bottom Line Is Not Enough.

作者: Jordana B Cohen.;Tammy M Brady.
来源: Circulation. 2022年145卷2期94-96页

5939. Response by Denfeld et al to Letter Regarding Article, "Characterizing Sex Differences in Physical Frailty Phenotypes in Heart Failure".

作者: Quin E Denfeld.;Kerri Winters-Stone.;S Albert Camacho.;Christopher S Lee.
来源: Circ Heart Fail. 2022年15卷3期e009317页

5940. Comparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial).

作者: Kamran Ahmed Khan.;Nadeem Qamar.;Tahir Saghir.;Jawaid Akbar Sial.;Dileep Kumar.;Rajesh Kumar.;Danish Qayyum.;Umamah Yasin.;Javed Jalbani.;Musa Karim.
来源: Circ Cardiovasc Interv. 2022年15卷2期e011408页
Intracoronary epinephrine has been effectively used in treating refractory no-reflow, but there is a dearth of data on its use as a first-line drug in normotensive patients in comparison to the widely used adenosine.
共有 7728 条符合本次的查询结果, 用时 4.2090774 秒